Elanco Animal Health Incorporated (ELAN) vs Liquidia Corporation (LQDA)
Elanco Animal Health Incorporated and Liquidia Corporation are both Drug Manufacturers Specialty & Generic companies. Elanco Animal Health Incorporated is the larger, with a market value of $11.2B against $6.4B — 1.8× the size. Elanco Animal Health Incorporated has negative trailing earnings, so its P/E is not meaningful; Liquidia Corporation trades at 43.6×. Liquidia Corporation grew revenue faster over the last twelve months: 2,233.7% against 12.0%. Liquidia Corporation has the higher net margin (30.7% vs −3.96%) and the higher return on invested capital (121.1% vs 0.51%). Across the 20 metrics below, Liquidia Corporation leads on 13 and Elanco Animal Health Incorporated on 7.
Valuation
Profitability
| Metric | ELAN | LQDA | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 55.36% | 92.54% | 53.94% |
| Operating margin | 1.61% | 37.39% | 0.00% |
| Net margin | (3.96%) | 30.74% | 0.00% |
| Free cash flow margin | 7.55% | 33.42% | 0.00% |
| Return on equity | (2.98%) | 131.82% | (0.40%) |
| Return on assets | (1.46%) | 35.57% | (3.32%) |
| Return on invested capital | 0.51% | 121.05% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack